Seeking Alpha

Alnylam Pharmaceuticals (ALNY -1.7%) and Genzyme, a Sanofi (SNY -0.4%) company, team up to...

Alnylam Pharmaceuticals (ALNY -1.7%) and Genzyme, a Sanofi (SNY -0.4%) company, team up to develop and commercialize RNAi therapeutics targeting transthyretin for the treatment of transthyretin-mediated amyloidosis in Japan and other Asia-Pacific countries.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)